BioHealth News
Calling all MedTech innovators: Up to $100,000 in federal grants to be awarded
Application deadline is Feb. 15 for the pandemic network edition of “Make Your Medical Device Pitch for Kids!™ WASHINGTON, Jan. 29, 2024 (GLOBE NEWSWIRE)…
Read More
The Daily Record: New Johns Hopkins institute aims to make Baltimore an AI hub
Johns Hopkins University has launched an ambitious endeavor that the school’s leaders say will make Baltimore a hub of the booming artificial intelligence industry.…
Read More
PQE Group: 100+M€ In Revenues, Expansion In Emerging Markets and Business Lines
Florence, Jan. 26, 2024 – PQE Group, the renowned Life Science consulting powerhouse, concludes the fiscal year 2023 with a 10% growth and an…
Read More
First Patient Enrolled in Rockville’s Rise Therapeutics’ Rheumatoid Arthritis Clinical Trial
ROCKVILLE, Md., Jan. 29, 2024 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced that it has enrolled its first…
Read More
QIAGEN announces partnership with Penn State University to advance microbiome sciences
Germantown, Maryland, and State College, Pennsylvania, Jan. 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a first-in-kind collaboration…
Read More
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
ROCKVILLE, Md., and SYDNEY, Australia, Jan. 23, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform…
Read More
Technical.ly: ETC, One of Baltimore’s Oldest Entrepreneurship Incubators, Names Arti Santhanam as New Executive Director
After a period of leadership transition and strategic planning, the organizations behind one of Baltimore’s longest-standing entrepreneurial communities have appointed a new executive director…
Read More
Haystack Oncology and TriSalus Life Sciences Enter Research Collaboration
BALTIMORE, Jan. 22, 2024 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company and developer of best-in-class personalized MRD technology (Haystack MRD™), has entered a research…
Read More
UMB Researchers Aim to Enhance Vaccines with $9.4M NIH Grant
January 16, 2024 - By Laura Lee - Principal Investigator Robert K. Ernst, PhD, the Dr. Paul and Mrs. Jean Corcoran Endowed Professor and chair of the Department of Microbial…
Read More
STEMCELL Technologies Announces Acquisition of Gaithersburg’s Propagenix Inc.
VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing…
Read More
Genetic Engineering & Biotechnology News: AI in Drug Discovery: Trust, but Verify
Tiffany Yesavage, PhD - January 11, 2024 - The use of artificial intelligence (AI) to develop new drugs is in its infancy. Nevertheless, AI-designed drugs have…
Read More
Virginia Catalyst Announces Grant Round 15 Awarded Projects
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2.2 million in grants to…
Read More
BioHealth Innovation, Inc.’s Rich Bendis Named Finalist for the Community Builder Award in the 2023 BioHealth Capital Region Annual Awards
Rockville, MD – BioHealth Innovation, Inc. (BHI) is proud to announce that our Founder, President & CEO, Rich Bendis, has been named a finalist…
Read More
Luminoah’s Receives $463,000 Grant from Virginia Catalyst
CHARLOTTESVILLE, VA – January 11, 2024 – Luminoah Inc., a medical technology company dedicated to improving the standard of care for patients requiring enteral nutrition,…
Read More
REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery
ROCKVILLE, Md., Jan. 16, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced positive interim data from the Phase II AAVIATE® trial of ABBV-RGX-314…
Read More